US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 28.620
  • +0.470+1.67%
Trading Apr 29 15:26 ET
18.56BMarket Cap30.22P/E (TTM)

Genmab Key Stats

Genmab Earnings Date

Currency: DKK

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

3.99B

+39.68%
EPS(YoY)

1.24

+258.42%

Buy

Apr 29, 2024

Genmab Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242024/Q2-- / 4.964B--
May 2, 20242024/Q1-- / 3.987B--
Feb 14, 20242023/Q44.678B / 4.610B--
Nov 7, 20232023/Q34.744B / 4.474B--
Aug 3, 20232023/Q24.198B / 4.070B--
May 10, 20232023/Q12.854B / 2.809B--
Feb 22, 20232022/Q45.227B / 4.727B--
Nov 9, 20222022/Q34.087B / 3.634B--
Aug 10, 20222022/Q23.162B / 2.833B--
May 11, 20222022/Q12.119B / 2.074B--
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242024/Q2-- / 4.964B--
May 2, 20242024/Q1-- / 3.987B--
Feb 14, 20242023/Q44.678B / 4.610B--
Nov 7, 20232023/Q34.744B / 4.474B--
Aug 3, 20232023/Q24.198B / 4.070B--
May 10, 20232023/Q12.854B / 2.809B--
Feb 22, 20232022/Q45.227B / 4.727B--
Nov 9, 20222022/Q34.087B / 3.634B--
Aug 10, 20222022/Q23.162B / 2.833B--
May 11, 20222022/Q12.119B / 2.074B--

Unlock Free Earnings Estimates

Genmab Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 29, 2024

Buy

  • Buy

    57.14%
  • Hold

    42.86%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg